H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 12% of adults in Chicago have diagnosed diabetes — about even with the U.S. 12% figure. Census population 2,693,976. Illinois Medicare wound biologics: National Government Services (NGS) (J6). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Chicago clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Chicago storefront.
Non-Surgical Regenerative Therapy Options in Chicago, IL for clinics & physicians. Give patients non-surgi… Compliance support & pricing — contact Hawk Medical.
CDC PLACES (2023, crude) estimates 12% of adults in Chicago have diagnosed diabetes — about even with the U.S. 12% figure. Obesity 32.6%; arthritis 19.6%. Those three PLACES crude rates (plus Census 2,693,976) are the local facts on this page. Everything else is the national non surgical regenerative therapy catalog and J6 paperwork.
National Non-Surgical Regenerative Therapy Options notes (how the product actually works)13.6% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. A city of 1M+ with 2,693,976 residents will still mix those payers. CDC PLACES (2023, crude) estimates 12% of adults in Chicago have diagnosed diabetes — about even with the U.S. 12% figure. Build two utilization policies if you do both cash PRP and Medicare CTPs.
The 96.5% hematogel figure on our wound materials is product-level clinical experience, not a Chicago trial. Local outcomes stay with the treating physician. CDC PLACES (2023, crude) estimates 12% of adults in Chicago have diagnosed diabetes — about even with the U.S. 12% figure. Use that rate for inventory math, not for ads.
CDC PLACES (2023, crude prevalence) estimates 12% of adults — about even with the U.S. 12% figure. Obesity is 32.6%; arthritis is 19.6%. That is place-level BRFSS modeling, not a clinic census and not a Chicago trial.
Yes. Tissue products come from FDA-registered banks with donor screening and lot traceability. Your receiving SOP should file IFU, lot, and indication with the chart. That packet is what J6 reviewers and surveyors expect — not a brochure.
It is the Census city-proper count — useful as scale for a city of 1M+. It is not a count of orthopedic groups, wound centers, or competitors. Underwrite the program against your referral sources, not against the skyline.
Regulatory lane, storage, and J6 coding. Amniotic products used as 361 HCT/Ps are not “better gauze.” Match wound stage and coverage article before you convert the cart.
Bring specialty, monthly joint / regenerative volume, and whether you bill J6 FFS, Advantage, workers’ comp, or cash-pay. We already have PLACES 12% diabetes and 19.6% arthritis for Chicago — tell us how that matches your panel. Book 15 minutes with Joe or use the contact form.
Contact us to learn how Hawk Medical supports practices in Chicago, IL.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Chicago is J6 geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Chicago — about even with the U.S. 12% figure. Planning input, not an outcomes claim.
Illinois Part B wound biologics follow this contractor (siblings: MN, WI). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Chicago. Useful for joint-program math; still needs a diagnosis and privileging.
No Chicago storefront. Joe Bradley is an active practice owner. non surgical regenerative therapy stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.